Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53

Hepatocellular carcinoma (HCC) is a prevalent problem worldwide. Chemotherapy, especially cisplatin (CDDP)-based systemic chemotherapy, is the best option for advanced liver cancer. However, CDDP resistance is becoming common and hindering the clinical application of CDDP. Meanwhile, no consensus ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhanjun, Tu, Min, Han, Bei, Gu, Yuqing, Xue, Xiaofeng, Sun, Jie, Ge, Qianqian, Miao, Yi, Qian, Zhuyin, Gao, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942424/
https://www.ncbi.nlm.nih.gov/pubmed/24595063
http://dx.doi.org/10.1371/journal.pone.0090358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942424/
https://www.ncbi.nlm.nih.gov/pubmed/24595063
http://dx.doi.org/10.1371/journal.pone.0090358

Ejemplares similares